相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis
Sima Lev
BIOCHEMICAL SOCIETY TRANSACTIONS (2020)
Role of Immunotherapy in Triple-Negative Breast Cancer
Tanya E. Keenan et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer
Mengru Wang et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2019)
Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
Peng Guo et al.
SCIENCE ADVANCES (2019)
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
Ru Zhou et al.
FRONTIERS IN IMMUNOLOGY (2019)
Activation of human vascular endothelium in melanoma metastases induces ICAM-1 and E-selectin expression and results in increased infiltration with effector lymphocytes
Carsten Weishaupt et al.
EXPERIMENTAL DERMATOLOGY (2019)
HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice
Elin M. V. Forsberg et al.
CANCER RESEARCH (2019)
EGFR-specific CAR-T cells trigger cell lysis in EGFR-positive TNBC
Yan Liu et al.
AGING-US (2019)
CD19-directed CAR T cells gain traction
Stephen J. Schuster
LANCET ONCOLOGY (2019)
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer
Wei Cao et al.
BREAST CANCER RESEARCH (2019)
Using Atomic Force Microscopy to Predict Tumor Specificity of ICAM1 Antibody-Directed Nanomedicines
P. Guo et al.
NANO LETTERS (2018)
Chimeric Antigen Receptor Therapy
Carl H. June et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
ICAM1 expression is induced by proinflammatory cytokines and associated with TLS formation in aggressive breast cancer subtypes
Stine L. Figenschau et al.
SCIENTIFIC REPORTS (2018)
Triple-negative breast cancer and the potential for targeted therapy
Jing-Ru Jhan et al.
PHARMACOGENOMICS (2017)
Targeted Disruption of V600E-Mutant BRAFGene by CRISPR-Cpf1
Meijia Yang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors
Irene M. Min et al.
CLINICAL CANCER RESEARCH (2017)
Chimeric antigen receptors: driving immunology towards synthetic biology
Michel Sadelain
CURRENT OPINION IN IMMUNOLOGY (2016)
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
David T. Teachey et al.
CANCER DISCOVERY (2016)
Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors
Yogindra Vedvyas et al.
JCI INSIGHT (2016)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Chimeric Antigen Receptor Therapy for Cancer
David M. Barrett et al.
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
ICAM-1 as a molecular target for triple negative breast cancer
Peng Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain et al.
CANCER DISCOVERY (2013)
Triple negative breast cancers: Clinical and prognostic implications
S.J. Dawson et al.
EUROPEAN JOURNAL OF CANCER (2009)
Anti-peptide antibody screening: Selection of high affinity monoclonal reagents by a refined surface plasmon resonance technique
Matthew E. Pope et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Selection of human antibody fragments by phage display
Carol M. Y. Lee et al.
NATURE PROTOCOLS (2007)
A novel anticancer effect of thalidomide:: Inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-κB
Yi-Chu Lin et al.
CLINICAL CANCER RESEARCH (2006)
ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-α-activated vascular endothelium under flow
L Yang et al.
BLOOD (2005)
Inhibition of ICAM-1 gene expression, monocyte adhesion and cancer cell invasion by targeting IKK complex:: molecular and functional study of novel α-methylene-γ-butyrolactone derivatives
WC Huang et al.
CARCINOGENESIS (2004)
ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer
Y Maruo et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Adhesion molecules in human pancreatic cancer
AA Tempia-Caliera et al.
JOURNAL OF SURGICAL ONCOLOGY (2002)
Expression of VCAM-1, ICAM-1, E- and P-selectin and tumour-associated macrophages in renal cell carcinoma
B Hemmerlein et al.
HISTOPATHOLOGY (2000)
分享论文
